Announcements Trials
Browse Landscape

Phase

Phase 2 4

Status

Not yet recruiting 4Recruiting 2

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gynecologic 4Other 2Breast 1

Conditions

Endometrial Neoplasms 3Endometrial Hyperplasia 2Obesity 1Hyperplasia 1

Interventions

Paclitaxel 24Carboplatin 18Bevacizumab 14Cisplatin 12pembrolizumab 7fluzoparib 7Drug Therapy 7Radiotherapy 6camrelizumab 5apatinib 5Topotecan 5Magnetic Resonance Spectroscopy 5Injections 5liposomal doxorubicin 4lenvatinib 4famitinib 4Tirzepatide 4Specimen Handling 4Platinum 4Observation 4Gemcitabine 4Brachytherapy 4toripalimab 3olaparib 3dostarlimab 3anlotinib 3Watchful Waiting 3Therapeutics 3Surveys and Questionnaires 3Neoadjuvant Therapy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Not yet recruiting × Tirzepatide × Gynecologic × Clear all
NCT07078838 2026-06-04

Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial Cancer

UNC Lineberger Comprehensive Cancer Center

Phase 2 Not yet recruiting
40 enrolled
GynecologicOther

Endometrial Hyperplasia, Hyperplasia, Obesity, Endometrial Neoplasms

NCT07605247 2026-05-22

TREAT-EC

Rutgers, The State University of New Jersey

Phase 2 Not yet recruiting
30 enrolled
Gynecologic

Endometrial Neoplasms

NCT07349641 2026-05-14

A Study of Weight Loss Intervention With Tirzepatide and Progestin Intrauterine Device to Treat Endometrial Hyperplasia and Grade 1 Endometrial Cancer

National Cancer Institute (NCI)

Phase 2 Not yet recruiting
55 enrolled
Gynecologic

Endometrial Hyperplasia

NCT06073184 2025-06-10

WE-FiERCE

University Health Network, Toronto

Phase 2 Not yet recruiting
71 enrolled
Gynecologic

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡